https://news.medxy.ai/zh/71262-2/Medxy AIzh2026-09-06T10:15:16-07:00VCTE 测定的肝脏硬度降低 30%可能作为MASH 组织学改善的关键指标？ https://news.medxy.ai/ja/liver-stiffness-decrease/Medxy AIja2026-09-06T10:14:46-07:00MASHにおける組織学的改善を見抜く鍵：VCTE由来肝硬度が30％低下したときの臨床的意義 https://news.medxy.ai/vi/71257-2/Medxy AIvi2026-09-06T10:14:11-07:00Chìa khóa xác định sự cải thiện về mô học trong MASH: Ý nghĩa lâm sàng của việc giảm 30% độ cứng gan đo bằng VCTE https://news.medxy.ai/clinical-utility-of-a-30-reduction-in-vcte-derived-liver-stiffness-measurement-for-identifying-histologic-improvement-in-metabolic-dysfunction-associated-steatohepatitis/Medxy AIen2026-09-06T10:13:33-07:00Clinical Utility of a 30% Reduction in VCTE-Derived Liver Stiffness Measurement for Identifying Histologic Improvement in Metabolic Dysfunction-Associated Steatohepatitis https://news.medxy.ai/zh/71748-2/Medxy AIzh2026-09-06T10:12:55-07:00妊娠期抗癫痫药物浓度的变化及多药联合治疗的影响 https://news.medxy.ai/zh/colorectal-cancer-surveillance/Medxy AIzh2026-09-06T10:12:41-07:00重新审视炎症性肠病中的结直肠癌监测：家族史的作用不应仅限于早发病例 https://news.medxy.ai/ja/71746-2/Medxy AIja2026-09-06T10:12:34-07:00抗てんかん薬血中濃度の妊娠に伴う変動と多剤併用療法の影響 https://news.medxy.ai/ja/colorectal-cancer-surveillance-3/Medxy AIja2026-09-06T10:12:18-07:00炎症性腸疾患における大腸がんサーベイランスの再考：早発性例だけではない家族歴の重要性 https://news.medxy.ai/vi/71744-2/Medxy AIvi2026-09-06T10:12:13-07:00Những thay đổi về nồng độ thuốc chống co giật trong thai kỳ và tác động của liệu pháp đa thuốc https://news.medxy.ai/vi/colorectal-cancer-surveillance-2/Medxy AIvi2026-09-06T10:11:51-07:00Rà soát lại chiến lược giám sát ung thư đại trực tràng ở bệnh viêm ruột: Vai trò của tiền sử gia đình vượt ra ngoài các trường hợp khởi phát sớm https://news.medxy.ai/reevaluating-colorectal-cancer-surveillance-in-inflammatory-bowel-disease-the-role-of-family-history-beyond-early-onset-cases/Medxy AIen2026-09-06T10:11:28-07:00Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset Cases https://news.medxy.ai/zh/tapis-trial-insights/Medxy AIzh2026-09-06T10:10:47-07:00中度缺血性卒中溶栓后替格瑞洛-阿司匹林双联治疗：TAPIS 试验中梗死模式带来的启示 https://news.medxy.ai/ja/dual-antiplatelet-therapy-2/Medxy AIja2026-09-06T10:10:21-07:00中等度虚血性脳卒中の血栓溶解後におけるチカグレロル・アスピリン二重療法：TAPIS試験にみる梗塞パターンの示唆 https://news.medxy.ai/vi/ticagrelor-aspirin-ischemic-stroke/Medxy AIvi2026-09-06T10:09:49-07:00Ticagrelor-aspirin sau tiêu sợi huyết trong đột quỵ thiếu máu cục bộ mức độ vừa: Gợi ý từ kiểu hình nhồi máu trong thử nghiệm TAPIS https://news.medxy.ai/ticagrelor-aspirin-dual-therapy-after-thrombolysis-in-moderate-ischemic-stroke-insights-from-infarct-patterns-in-the-tapis-trial/Medxy AIen2026-09-06T10:09:23-07:00Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS Trial https://news.medxy.ai/zh/cilostazol-neuroprotection/Medxy AIzh2026-09-06T10:08:38-07:00西洛他唑治疗脑内出血：通过增强硬脑膜淋巴功能实现神经保护 https://news.medxy.ai/ja/cilostazol-neuroprotection-2/Medxy AIja2026-09-06T10:08:11-07:00脳内出血に対するシロスタゾール治療：硬膜リンパ管機能を高めて神経保護をめざす https://news.medxy.ai/vi/cilostazol-brain-hemorrhage/Medxy AIvi2026-09-06T10:07:45-07:00Cilostazol trong điều trị xuất huyết não: tăng cường chức năng bạch mạch màng cứng để bảo vệ thần kinh https://news.medxy.ai/cilostazol-therapy-in-intracerebral-hemorrhage-enhancing-dural-lymphatic-function-for-neuroprotection/Medxy AIen2026-09-06T10:07:15-07:00Cilostazol Therapy in Intracerebral Hemorrhage: Enhancing Dural Lymphatic Function for Neuroprotection https://news.medxy.ai/zh/csf-markers-severity/Medxy AIzh2026-09-06T10:06:18-07:00脑脊液生物标志物能否提示疑似脑淀粉样血管病的严重程度？MRI之外的新线索 https://news.medxy.ai/ja/brain-amyloid-angiopathy/Medxy AIja2026-09-06T10:05:47-07:00CSFバイオマーカーでみる脳アミロイドアンギオパチーの重症度：MRIを超えて見える病態 https://news.medxy.ai/vi/71223-2/Medxy AIvi2026-09-06T10:05:16-07:00Liệu các dấu ấn sinh học trong dịch não tủy có thể phản ánh mức độ nghiêm trọng của nghi vấn bệnh lý mạch máu não dạng amyloid? Những manh mối mới bên cạnh hình ảnh cộng hưởng từ (MRI) https://news.medxy.ai/csf-biomarkers-as-indicators-of-disease-severity-in-probable-cerebral-amyloid-angiopathy-insights-beyond-mri/Medxy AIen2026-09-06T10:04:46-07:00CSF Biomarkers as Indicators of Disease Severity in Probable Cerebral Amyloid Angiopathy: Insights Beyond MRI https://news.medxy.ai/zh/temporal-lobe-epilepsy-mechanisms/Medxy AIzh2026-09-06T10:03:54-07:00颞叶癫痫中枢自主神经网络紊乱与心肺功能异常有关？ https://news.medxy.ai/ja/central-autonomic-network/Medxy AIja2026-09-06T10:03:30-07:00側頭葉てんかんにおける心肺機能障害の背景にある中枢自律神経ネットワーク異常を解明する https://news.medxy.ai/vi/central-autonomic-dysfunction/Medxy AIvi2026-09-06T10:03:07-07:00Giải mã rối loạn mạng tự chủ trung ương nền tảng cho suy giảm tim hô hấp ở động kinh thùy thái dương https://news.medxy.ai/unraveling-central-autonomic-network-disruptions-underlying-cardiorespiratory-dysfunction-in-temporal-lobe-epilepsy/Medxy AIen2026-09-06T10:02:40-07:00Unraveling Central Autonomic Network Disruptions Underlying Cardiorespiratory Dysfunction in Temporal Lobe Epilepsy https://news.medxy.ai/zh/71207-2/Medxy AIzh2026-09-06T10:01:51-07:001型糖尿病患者的儿科亲属（以同胞为主）中的自身抗体筛查：患病率、决定因素及心理影响 https://news.medxy.ai/ja/type-1-diabetes-siblings/Medxy AIja2026-09-06T10:01:26-07:001型糖尿病患者のきょうだいに着目した小児第一度近親者における自己抗体スクリーニング：有病率・規定因子・心理的影響 https://news.medxy.ai/vi/type-1-diabetes-antibody-screening/Medxy AIvi2026-09-06T10:00:52-07:00Sàng lọc tự kháng thể ở thân nhân trẻ em của bệnh nhân đái tháo đường týp 1, chủ yếu là anh chị em ruột: Tỷ lệ hiện mắc, yếu tố liên quan và tác động tâm lý https://news.medxy.ai/autoantibody-screening-in-sibling-dominant-pediatric-relatives-of-type-1-diabetes-patients-prevalence-determinants-and-psychological-impact/Medxy AIen2026-09-06T10:00:28-07:00Autoantibody Screening in Sibling-Dominant Pediatric Relatives of Type 1 Diabetes Patients: Prevalence, Determinants, and Psychological Impact https://news.medxy.ai/zh/infertility-diabetes-risk-2/Medxy AIzh2026-09-06T09:59:29-07:00不孕史会增加2型糖尿病风险吗？——护士健康研究II揭示的关键线索 https://news.medxy.ai/ja/infertility-diabetes-risk/Medxy AIja2026-09-06T09:59:05-07:00不妊歴と2型糖尿病リスクの関連を探る： Nurses’ Health Study II からの知見 https://news.medxy.ai/vi/female-infertility-diabetes-risk/Medxy AIvi2026-09-06T09:58:39-07:00Tiền sử vô sinh nữ liên quan thế nào đến nguy cơ đái tháo đường type 2? Dữ liệu từ Nurses’ Health Study II https://news.medxy.ai/female-infertility-diabetes-risk-2/Medxy AIen2026-09-06T09:58:11-07:00Linking Female Infertility History to Type 2 Diabetes Risk: Insights from the Nurses’ Health Study II https://news.medxy.ai/zh/71186-2/Medxy AIzh2026-09-06T09:57:27-07:00血液系统恶性肿瘤患儿睾丸功能的纵向评估：见解与临床意义 https://news.medxy.ai/ja/testicular-function-boys-cancer/Medxy AIja2026-09-06T09:56:57-07:00血液悪性腫瘍を有する男児の精巣機能を経時的に評価する：知見と臨床的意義 https://news.medxy.ai/vi/71184-2/Medxy AIvi2026-09-06T09:56:22-07:00Đánh giá dọc chức năng tinh hoàn ở trẻ nam mắc các bệnh ác tính về huyết học: Những hiểu biết và ý nghĩa lâm sàng https://news.medxy.ai/longitudinal-assessment-of-testicular-function-in-boys-with-hematological-malignancies-insights-and-clinical-implications/Medxy AIen2026-09-06T09:55:50-07:00Longitudinal Assessment of Testicular Function in Boys with Hematological Malignancies: Insights and Clinical Implications https://news.medxy.ai/zh/sarcopenic-obesity-diabetes-risk/Medxy AIzh2026-09-06T09:54:53-07:00肌少性肥胖与2型糖尿病风险：来自 UK Biobank 研究的启示 https://news.medxy.ai/ja/sarcopenic-obesity-diabetes-risk-2/Medxy AIja2026-09-06T09:54:28-07:00サルコペニック肥満は2型糖尿病リスクをどこまで高めるのか？ UK Biobank研究が示した新知見 https://news.medxy.ai/vi/obesity-muscle-loss-diabetes-risk/Medxy AIvi2026-09-06T09:54:00-07:00Béo phì kèm giảm cơ và nguy cơ đái tháo đường type 2: Gợi ý từ nghiên cứu UK Biobank https://news.medxy.ai/sarcopenic-obesity-and-type-2-diabetes-risk-insights-from-the-uk-biobank-study/Medxy AIen2026-09-06T09:53:37-07:00Sarcopenic Obesity and Type 2 Diabetes Risk: Insights from the UK Biobank Study https://news.medxy.ai/zh/71171-2/Medxy AIzh2026-09-06T09:52:58-07:001型糖尿病患者月经周期对胰岛素敏感性的影响：来自自动胰岛素输注系统使用者的见解 https://news.medxy.ai/ja/71169-2/Medxy AIja2026-09-06T09:52:35-07:001型糖尿病におけるインスリン感受性への月経周期の影響：自動インスリン投与システム使用者からの知見 https://news.medxy.ai/vi/menstrual-cycle-insulin-sensitivity/Medxy AIvi2026-09-06T09:52:06-07:00Chu kỳ kinh nguyệt ảnh hưởng thế nào đến độ nhạy insulin ở đái tháo đường týp 1? Góc nhìn từ người dùng hệ thống truyền insulin tự động https://news.medxy.ai/menstrual-cycle-influence-on-insulin-sensitivity-in-type-1-diabetes-insights-from-automated-insulin-delivery-users/Medxy AIen2026-09-06T09:51:39-07:00Menstrual Cycle Influence on Insulin Sensitivity in Type 1 Diabetes: Insights from Automated Insulin Delivery Users https://news.medxy.ai/zh/obesity-driven-afib/Medxy AIzh2026-09-06T09:50:56-07:00肥胖驱动的心房颤动患者左心房重构：来自有创压力-容积分析的启示 https://news.medxy.ai/ja/71161-2/Medxy AIja2026-09-06T09:50:31-07:00心房細動における肥満に起因する左房リモデリング：侵襲的圧・容積解析による知見 https://news.medxy.ai/vi/71159-2/Medxy AIvi2026-09-06T09:50:02-07:00Tái cấu trúc tâm nhĩ trái do béo phì trong rung nhĩ: Những hiểu biết từ phân tích xâm lấn mối tương quan áp lực – thể tích https://news.medxy.ai/obesity-driven-left-atrial-remodeling-in-atrial-fibrillation-insights-from-invasive-pressure-volume-analysis/Medxy AIen2026-09-06T09:49:34-07:00Obesity-Driven Left Atrial Remodeling in Atrial Fibrillation: Insights from Invasive Pressure-Volume Analysis https://news.medxy.ai/zh/left-ventricle-right-atria-strain/Medxy AIzh2026-09-06T09:48:51-07:00左心室与右心房应变联合评估：提升肺动脉高压预后预测的新策略 https://news.medxy.ai/ja/71152-2/Medxy AIja2026-09-06T09:48:31-07:00肺動脈性肺高血圧症における予後予測精度の向上に向けた左室および右房ストレインの統合 https://news.medxy.ai/vi/left-ventricle-right-atrial-strain/Medxy AIvi2026-09-06T09:48:07-07:00Kết hợp biến dạng thất trái và nhĩ phải để nâng cao dự đoán tiên lượng trong tăng áp động mạch phổi https://news.medxy.ai/integrating-left-ventricular-and-right-atrial-strain-for-enhanced-prognostic-prediction-in-pulmonary-arterial-hypertension/Medxy AIen2026-09-06T09:47:39-07:00Integrating Left Ventricular and Right Atrial Strain for Enhanced Prognostic Prediction in Pulmonary Arterial Hypertension https://news.medxy.ai/zh/bilateral-vs-unilateral-ita/Medxy AIzh2026-09-06T09:46:58-07:00双侧与单侧胸廓内动脉移植在冠脉旁路手术中的长期结局比较 https://news.medxy.ai/ja/coronary-bypass-graft-comparison/Medxy AIja2026-09-06T09:46:34-07:00冠動脈バイパス術における両側内胸動脈グラフトと単独内胸動脈グラフトの長期成績比較 https://news.medxy.ai/vi/71139-2/Medxy AIvi2026-09-06T09:46:05-07:00So sánh kết quả dài hạn của phẫu thuật bắc cầu động mạch vành sử dụng động mạch vú trong hai bên so với một bên https://news.medxy.ai/long-term-comparative-outcomes-of-bilateral-versus-single-internal-thoracic-artery-grafts-in-coronary-bypass-surgery/Medxy AIen2026-09-06T09:45:44-07:00Long-Term Comparative Outcomes of Bilateral versus Single Internal Thoracic Artery Grafts in Coronary Bypass Surgery https://news.medxy.ai/zh/71133-2/Medxy AIzh2026-09-06T09:45:01-07:00多基因风险评分提升了对外周动脉疾病及肢体相关事件的预测能力 https://news.medxy.ai/ja/71130-2/Medxy AIja2026-09-06T09:44:39-07:00遺伝学的知見の活用：ポリジェニック・リスク・スコアが末梢動脈疾患および四肢イベントの予測能を向上させる https://news.medxy.ai/vi/71126-2/Medxy AIvi2026-09-06T09:44:15-07:00Tận dụng thông tin di truyền: Điểm nguy cơ đa gen giúp nâng cao khả năng dự báo bệnh động mạch ngoại biên và các biến cố chi https://news.medxy.ai/harnessing-genetic-insights-polygenic-risk-score-enhances-prediction-of-peripheral-artery-disease-and-limb-events/Medxy AIen2026-09-06T09:43:49-07:00Harnessing Genetic Insights: Polygenic Risk Score Enhances Prediction of Peripheral Artery Disease and Limb Events https://news.medxy.ai/zh/ryr2-cpvt-risk-model/Medxy AIzh2026-09-06T09:43:00-07:00RYR2介导CPVT在β受体阻滞剂治疗下的已验证风险分层模型 https://news.medxy.ai/ja/71118-2/Medxy AIja2026-09-06T09:42:38-07:00β遮断薬治療下におけるRYR2関連カテコラミン感受性多形性心室頻拍の検証済みリスク層別化 https://news.medxy.ai/vi/ryr2-cpvt-risk/Medxy AIvi2026-09-06T09:42:14-07:00Phân tầng nguy cơ đã được xác thực ở CPVT trung gian bởi RYR2 trong điều trị bằng thuốc chẹn beta https://news.medxy.ai/validated-risk-stratification-for-ryr2-mediated-catecholaminergic-polymorphic-ventricular-tachycardia-on-beta-blocker-therapy/Medxy AIen2026-09-06T09:41:50-07:00Validated Risk Stratification for RYR2-Mediated Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker Therapy https://news.medxy.ai/zh/stent-thrombectomy-infarct-reduction/Medxy AIzh2026-09-06T09:41:09-07:00支架取栓可缩小高血栓负荷心肌梗死的梗死面积：NATURE 试验带来的新启示 https://news.medxy.ai/ja/stent-thrombectomy-effectiveness/Medxy AIja2026-09-06T09:40:46-07:00高血栓負荷心筋梗塞におけるステントリトリーバー血栓除去術の有効性：NATURE試験から見えた梗塞縮小効果 https://news.medxy.ai/vi/71106-2/Medxy AIvi2026-09-06T09:40:22-07:00Thủ thuật lấy huyết khối bằng stent retriever giúp giảm kích thước vùng nhồi máu ở bệnh nhân nhồi máu cơ tim có khối lượng huyết khối lớn: Những thông tin từ thử nghiệm NATURE https://news.medxy.ai/stent-retriever-thrombectomy-reduces-infarct-size-in-high-thrombus-myocardial-infarction-insights-from-the-nature-trial/Medxy AIen2026-09-06T09:39:58-07:00Stent Retriever Thrombectomy Reduces Infarct Size in High-Thrombus Myocardial Infarction: Insights from the NATURE Trial https://news.medxy.ai/zh/lepodisiran-lipoprotein-a-impact/Medxy AIzh2026-09-06T09:39:16-07:00Lepodisiran 对脂蛋白(a)中氧化磷脂的影响：推动心血管风险降低研究 https://news.medxy.ai/ja/71098-2/Medxy AIja2026-09-06T09:38:53-07:00リポタンパク(a)中の酸化リン脂質に対するレポディシラン（Lepodisiran）の影響：心血管リスク低減に向けた研究の進展 https://news.medxy.ai/vi/71097-2/Medxy AIvi2026-09-06T09:38:26-07:00Tác động của Lepodisiran đối với Phospholipid bị oxy hóa trong Lipoprotein(a): Thúc đẩy nghiên cứu về giảm nguy cơ tim mạch https://news.medxy.ai/lepodisirans-impact-on-oxidized-phospholipids-in-lipoproteina-advancing-cardiovascular-risk-reduction/Medxy AIen2026-09-06T09:38:00-07:00Lepodisiran’s Impact on Oxidized Phospholipids in Lipoprotein(a): Advancing Cardiovascular Risk Reduction https://news.medxy.ai/zh/familial-hypercholesterolemia-diagnosis/Medxy AIzh2026-09-06T09:37:10-07:00突破家族性高胆固醇血症诊断：经活性归一化的 prime editing 实现 LDLR 变异全面分类 https://news.medxy.ai/ja/71092-2/Medxy AIja2026-09-06T09:36:46-07:00家族性高コレステロール血症の診断の進展：LDLRバリアントの包括的分類に向けた活性正規化プライム編集 https://news.medxy.ai/vi/71090-2/Medxy AIvi2026-09-06T09:36:17-07:00Thúc đẩy chẩn đoán Tăng cholesterol máu gia đình: Kỹ thuật Prime Editing được chuẩn hóa theo hoạt tính nhằm phân loại toàn diện các biến thể gen LDLR https://news.medxy.ai/advancing-familial-hypercholesterolemia-diagnosis-activity-normalized-prime-editing-for-comprehensive-ldlr-variant-classification/Medxy AIen2026-09-06T09:35:50-07:00Advancing Familial Hypercholesterolemia Diagnosis: Activity-Normalized Prime Editing for Comprehensive LDLR Variant Classification https://news.medxy.ai/zh/cxcl9-cxcl10-cd8-tcells-axis/Medxy AIzh2026-09-06T09:35:04-07:00瞄准CXCL9/CXCL10-CXCR3+ CD8+ T细胞轴：揭示压力负荷性心力衰竭中抗PD-1抗体相关心脏毒性的机制 https://news.medxy.ai/ja/71084-2/Medxy AIja2026-09-06T09:34:41-07:00CXCL9/CXCL10-CXCR3+ CD8+ T細胞軸を標的とする：圧負荷心不全における抗PD-1抗体関連心毒性の解明 https://news.medxy.ai/vi/cxcl9-cxcr3-cd8-tcells/Medxy AIvi2026-09-06T09:34:16-07:00Nhắm trục CXCL9/CXCL10-CXCR3+ trên tế bào T CD8+: Giải mã độc tính tim liên quan đến kháng thể kháng PD-1 trong suy tim do quá tải áp lực https://news.medxy.ai/targeting-the-cxcl9-cxcl10-cxcr3-cd8-t-cell-axis-unraveling-anti-pd-1-antibody-associated-cardiotoxicity-in-pressure-overload-heart-failure/Medxy AIen2026-09-06T09:33:51-07:00Targeting the CXCL9/CXCL10-CXCR3+ CD8+ T Cell Axis: Unraveling Anti-PD-1 Antibody-Associated Cardiotoxicity in Pressure Overload Heart Failure https://news.medxy.ai/zh/cd19-cd22-car-t/Medxy AIzh2026-09-06T09:33:06-07:00双靶点 CD19/CD22 CAR T 细胞疗法：儿童复发/难治性 B 细胞急性淋巴细胞白血病的新突破 https://news.medxy.ai/ja/dual-target-car-t-therapy-2/Medxy AIja2026-09-06T09:32:43-07:00小児再発・難治性B-ALLに挑む二重標的CAR T細胞療法：CD19/CD22の新展開 https://news.medxy.ai/vi/car-t-therapy-b-all-2/Medxy AIvi2026-09-06T09:32:13-07:00Liệu pháp CAR T tế bào nhị cấu trúc CD19/CD22: Bước tiến mới cho B-ALL tái phát/kháng trị ở trẻ em https://news.medxy.ai/bicistronic-cd19-cd22-car-t-cell-therapy-a-breakthrough-for-pediatric-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia/Medxy AIen2026-09-06T09:31:45-07:00Bicistronic CD19/CD22 CAR T-Cell Therapy: A Breakthrough for Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia https://news.medxy.ai/zh/her2-positive-breast-cancer-treatment-3/Medxy AIzh2026-09-06T09:31:03-07:00ERBB2阳性乳腺癌新辅助治疗新进展：anbenitamab联合HB1801的3期随机临床试验综述 https://news.medxy.ai/ja/erbb2-breast-cancer-trial/Medxy AIja2026-09-06T09:30:41-07:00ERBB2陽性乳がんにおける術前anbenitamab＋HB1801：第3相ランダム化比較試験レビュー https://news.medxy.ai/vi/71070-2/Medxy AIvi2026-09-06T09:30:13-07:00Những tiến bộ gần đây trong liệu pháp tân bổ trợ cho ung thư vú dương tính với ERBB2: Tổng quan về thử nghiệm lâm sàng ngẫu nhiên giai đoạn 3 đánh giá Anbenitamab kết hợp với HB1801 https://news.medxy.ai/neoadjuvant-anbenitamab-and-hb1801-in-erbb2-positive-breast-cancer-a-phase-3-randomized-clinical-trial-review/Medxy AIen2026-09-06T09:29:47-07:00Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial Review https://news.medxy.ai/zh/ophthalmology-study-incidence/Medxy AIzh2026-09-05T12:49:59-07:00眼科学中无显著差异研究的发生率与特征：2014—2025年综合分析 https://news.medxy.ai/ja/null-studies-ophthalmology/Medxy AIja2026-09-05T12:49:44-07:00眼科学におけるNull研究の頻度と特徴：2014年から2025年までの包括的解析 https://news.medxy.ai/vi/ophthalmology-study-results/Medxy AIvi2026-09-05T12:49:24-07:00Tỷ lệ và đặc điểm của các nghiên cứu không có kết quả trong nhãn khoa: Phân tích toàn diện giai đoạn 2014–2025 https://news.medxy.ai/prevalence-and-characteristics-of-null-studies-in-ophthalmology-a-comprehensive-analysis-from-2014-to-2025/Medxy AIen2026-09-05T12:49:06-07:00Prevalence and Characteristics of Null Studies in Ophthalmology: A Comprehensive Analysis from 2014 to 2025 https://news.medxy.ai/zh/prednisone-facial-paralysis/Medxy AIzh2026-09-05T12:48:17-07:00听神经瘤术后用泼尼松龙并不能预防延迟性面神经麻痹：回顾性分析 https://news.medxy.ai/ja/acetazolamide-facial-nerve-paralysis/Medxy AIja2026-09-05T12:47:59-07:00聴神経鞘腫手術後のプレドニゾンは遅発性顔面神経麻痺を防げない：後ろ向き解析 https://news.medxy.ai/vi/prednisone-auditory-nerve-surgery/Medxy AIvi2026-09-05T12:47:39-07:00Prednisone sau mổ u dây thần kinh thính giác không ngăn ngừa liệt dây thần kinh mặt muộn: Phân tích hồi cứu https://news.medxy.ai/prednisone-use-post-acoustic-neuroma-surgery-does-not-prevent-delayed-facial-nerve-palsy-a-retrospective-analysis/Medxy AIen2026-09-05T12:47:21-07:00Prednisone Use Post-Acoustic Neuroma Surgery Does Not Prevent Delayed Facial Nerve Palsy: A Retrospective Analysis https://news.medxy.ai/zh/custom-cochlear-implant-tools/Medxy AIzh2026-09-05T12:46:42-07:00为耳蜗植入术量身定制手术工具：3D打印颞骨模型对认知负荷的差异化影响 https://news.medxy.ai/ja/70832-2/Medxy AIja2026-09-05T12:46:24-07:00人工内耳埋め込み術用手術器具の最適化：3Dプリント側頭骨モデルが認知負荷に及ぼす差異的影響 https://news.medxy.ai/vi/customized-surgical-tools/Medxy AIvi2026-09-05T12:46:02-07:00Cá thể hóa dụng cụ phẫu thuật: Tác động khác nhau của mô hình xương thái dương in 3D lên tải nhận thức trong cấy ốc tai điện tử https://news.medxy.ai/tailoring-surgical-tools-the-differential-impact-of-3d-printed-temporal-bone-models-on-cognitive-load-in-cochlear-implantation/Medxy AIen2026-09-05T12:45:41-07:00Tailoring Surgical Tools: The Differential Impact of 3D-Printed Temporal Bone Models on Cognitive Load in Cochlear Implantation https://news.medxy.ai/zh/liver-cancer-prognosis/Medxy AIzh2026-09-05T12:44:52-07:00肝细胞癌预后分层再优化：血管侵犯类型与范围的关键作用 https://news.medxy.ai/ja/liver-cancer-prognosis-3/Medxy AIja2026-09-05T12:44:35-07:00肝細胞癌の予後層別化をさらに精緻化する：血管侵襲の種類と進展度が持つ決定的意義 https://news.medxy.ai/vi/liver-cancer-prognosis-2/Medxy AIvi2026-09-05T12:44:14-07:00Tinh chỉnh phân tầng tiên lượng trong ung thư biểu mô tế bào gan: Vai trò then chốt của kiểu và mức độ xâm lấn mạch máu https://news.medxy.ai/refining-prognostic-stratification-in-hepatocellular-carcinoma-the-critical-role-of-vascular-invasion-type-and-extent/Medxy AIen2026-09-05T12:43:57-07:00Refining Prognostic Stratification in Hepatocellular Carcinoma: The Critical Role of Vascular Invasion Type and Extent https://news.medxy.ai/zh/thyroid-hypothyroidism-risk/Medxy AIzh2026-09-05T12:43:12-07:00半甲状腺切除术后甲状腺功能减退风险预测：用于个体化评估的临床列线图开发与验证 https://news.medxy.ai/ja/thyroid-hypothyroidism-prediction/Medxy AIja2026-09-05T12:42:53-07:00甲状腺半葉切除後の低甲状腺機能症を予測する：個別化リスク評価のための臨床ノモグラムの開発と検証 https://news.medxy.ai/vi/hypothyroidism-prediction/Medxy AIvi2026-09-05T12:42:32-07:00Dự đoán suy giáp sau cắt một thùy tuyến giáp: Xây dựng và thẩm định một nomogram lâm sàng để đánh giá nguy cơ cá thể hóa https://news.medxy.ai/predicting-hypothyroidism-after-hemithyroidectomy-development-and-validation-of-a-clinical-nomogram-for-personalized-risk-assessment/Medxy AIen2026-09-05T12:42:10-07:00Predicting Hypothyroidism After Hemithyroidectomy: Development and Validation of a Clinical Nomogram for Personalized Risk Assessment https://news.medxy.ai/zh/gastric-cancer-molecular-evolution/Medxy AIzh2026-09-05T12:41:14-07:00从原发胃癌到腹膜转移：分子演变全景与靶向外科肿瘤学启示 https://news.medxy.ai/ja/gastric-cancer-metastasis/Medxy AIja2026-09-05T12:40:57-07:00原発胃癌から腹膜転移へ――分子進化の全貌と標的外科腫瘍学への示唆 https://news.medxy.ai/vi/molecular-evolution-cancer/Medxy AIvi2026-09-05T12:40:37-07:00Giải mã tiến hóa phân tử từ ung thư dạ dày nguyên phát đến di căn phúc mạc: Hàm ý cho phẫu thuật ung thư nhắm trúng đích https://news.medxy.ai/unveiling-the-molecular-evolution-from-primary-gastric-cancer-to-peritoneal-metastases-implications-for-targeted-surgical-oncology/Medxy AIen2026-09-05T12:40:18-07:00Unveiling the Molecular Evolution from Primary Gastric Cancer to Peritoneal Metastases: Implications for Targeted Surgical Oncology https://news.medxy.ai/zh/70801-2/Medxy AIzh2026-09-05T11:39:34-07:00负压疗法在下肢大截肢术中的应用：对现有随机对照试验的评述 https://news.medxy.ai/ja/70800-2/Medxy AIja2026-09-05T11:39:16-07:00下肢大腿切断における陰圧閉鎖療法：現行のランダム化比較試験に関する批判的レビュー https://news.medxy.ai/vi/negative-pressure-therapy-overview/Medxy AIvi2026-09-05T11:38:51-07:00Liệu pháp áp lực âm trong cắt cụt chi dưới lớn: Tổng quan phê bình các thử nghiệm ngẫu nhiên có đối chứng hiện nay https://news.medxy.ai/negative-pressure-therapy-in-major-lower-extremity-amputation-a-critical-review-of-current-randomized-controlled-trials/Medxy AIen2026-09-05T11:38:29-07:00Negative Pressure Therapy in Major Lower Extremity Amputation: A Critical Review of Current Randomized Controlled Trials https://news.medxy.ai/zh/late-pregnancy-sleep-growth/Medxy AIzh2026-09-05T11:37:28-07:00妊娠晚期孕妇仰卧睡眠与胎儿生长无关：一项前瞻性队列研究 https://news.medxy.ai/ja/late-pregnancy-sleep-position/Medxy AIja2026-09-05T11:37:06-07:00妊娠後期の仰臥位睡眠は胎児発育に影響するか？前向きコホート研究が示した結果 https://news.medxy.ai/vi/late-pregnancy-sleep/Medxy AIvi2026-09-05T11:36:46-07:00Ngủ nằm ngửa của mẹ ở cuối thai kỳ: Nghiên cứu đoàn hệ tiền cứu không ghi nhận ảnh hưởng đến tăng trưởng thai nhi https://news.medxy.ai/maternal-supine-sleep-in-late-pregnancy-no-impact-on-fetal-growth-in-prospective-cohort-study/Medxy AIen2026-09-05T11:36:28-07:00Maternal Supine Sleep in Late Pregnancy: No Impact on Fetal Growth in Prospective Cohort Study https://news.medxy.ai/zh/laparoscopic-uterus-preservation/Medxy AIzh2026-09-05T11:35:40-07:00腹腔镜保留子宫新术式：用于伴功能性子宫残余的宫颈阴道发育缺失 https://news.medxy.ai/ja/innovative-laparoscopic-hysterectomy/Medxy AIja2026-09-05T11:35:21-07:00機能性子宮遺残を伴う頸膣欠損症に対する革新的腹腔鏡下子宮温存手術 https://news.medxy.ai/vi/advanced-hysteroscopic-surgery/Medxy AIvi2026-09-05T11:34:57-07:00Phẫu thuật nội soi bảo tồn tử cung tiên tiến cho vô sản cổ tử cung–âm đạo có mô tử cung tồn lưu còn chức năng https://news.medxy.ai/innovative-laparoscopic-uterus-preserving-surgery-for-cervicovaginal-agenesis-with-functional-uterine-remnants/Medxy AIen2026-09-05T11:34:39-07:00Innovative Laparoscopic Uterus-Preserving Surgery for Cervicovaginal Agenesis with Functional Uterine Remnants https://news.medxy.ai/zh/fetal-growth-restriction-risk/Medxy AIzh2026-09-05T11:33:53-07:00慢性高血压孕妇的胎儿生长受限与叠加子痫前期风险：对临床监测的启示 https://news.medxy.ai/ja/70771-2/Medxy AIja2026-09-05T11:33:34-07:00慢性高血圧合併妊婦における胎児発育不全および重畳型子癇前症のリスク：臨床的モニタリングへの示唆 https://news.medxy.ai/vi/70769-2/Medxy AIvi2026-09-05T11:33:09-07:00Nguy cơ thai chậm tăng trưởng và tiền sản giật chồng lên tăng huyết áp mạn tính ở phụ nữ mang thai: Ý nghĩa đối với việc theo dõi lâm sàng https://news.medxy.ai/fetal-growth-restriction-and-risk-of-superimposed-preeclampsia-in-women-with-chronic-hypertension-implications-for-clinical-surveillance/Medxy AIen2026-09-05T11:32:47-07:00Fetal Growth Restriction and Risk of Superimposed Preeclampsia in Women with Chronic Hypertension: Implications for Clinical Surveillance https://news.medxy.ai/ja/preterm-premature-rupture/Medxy AIja2026-09-05T11:31:54-07:00早産前期破水における羊膜内4分類：妊娠週数別分布、羊水微生物プロファイル、新生児転帰 https://news.medxy.ai/vi/four-rupture-amniotic-fluid/Medxy AIvi2026-09-05T11:31:36-07:00Bốn nhóm trong buồng ối của vỡ ối non trước chuyển dạ: Phân bố theo tuổi thai, đặc điểm vi sinh dịch ối và kết cục sơ sinh https://news.medxy.ai/intra-amniotic-categories-of-preterm-prelabor-rupture-of-membranes-gestational-age-specific-distribution-amniotic-fluid-microbial-profiles-and-neonatal-outcomes/Medxy AIen2026-09-05T11:31:17-07:00Intra-amniotic Categories of Preterm Prelabor Rupture of Membranes: Gestational Age-Specific Distribution, Amniotic Fluid Microbial Profiles, and Neonatal Outcomes https://news.medxy.ai/zh/vibrator-use-benefits/Medxy AIzh2026-09-05T11:30:29-07:00按计划使用振动器能改善女性性与盆底健康：一项随机对照试验证据 https://news.medxy.ai/ja/pelvic-health-vibrator/Medxy AIja2026-09-05T11:30:11-07:00女性の性と骨盤の健康を高める：ランダム化比較試験における予定的バイブレーター使用の有効性 https://news.medxy.ai/vi/sexual-health-improvement/Medxy AIvi2026-09-05T11:29:50-07:00Cải thiện sức khỏe tình dục và sàn chậu ở phụ nữ: hiệu quả của việc sử dụng máy rung theo lịch trong một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/enhancing-sexual-and-pelvic-health-in-women-efficacy-of-scheduled-vibrator-use-in-a-randomized-controlled-trial/Medxy AIen2026-09-05T11:29:29-07:00Enhancing Sexual and Pelvic Health in Women: Efficacy of Scheduled Vibrator Use in a Randomized Controlled Trial https://news.medxy.ai/ja/70741-2/Medxy AIja2026-09-05T11:28:39-07:00連邦規制の最新情報：妊婦労働者公正法（PWFA）が変える産婦人科医療とカウンセリング https://news.medxy.ai/vi/pwfa-maternal-care/Medxy AIvi2026-09-05T11:28:06-07:00Quy định liên bang mới: PWFA thay đổi chăm sóc và tư vấn sản khoa như thế nào https://news.medxy.ai/zh/pwfa-pregnancy-law/Medxy AIzh2026-09-05T11:27:33-07:00联邦法规更新：妊娠劳动者公平法（PWFA）如何改变妇产科照护与咨询 https://news.medxy.ai/updated-federal-regulation-how-the-pregnant-workers-fairness-act-pwfa-changes-care-and-counseling-in-obstetrics/Medxy AIen2026-09-05T11:27:07-07:00Updated Federal Regulation: How the Pregnant Workers Fairness Act (PWFA) Changes Care and Counseling in Obstetrics https://news.medxy.ai/zh/cpeb3-alt-polyadenylation/Medxy AIzh2026-09-05T11:26:03-07:00解读CPEB3调控的替代性多聚腺苷酸化：肝细胞癌预后的全新遗传视角 https://news.medxy.ai/ja/cpeb3-alternative-polyadenylation/Medxy AIja2026-09-05T11:25:47-07:00CPEB3が制御する代替ポリアデニル化を読み解く：肝細胞癌予後を捉える新たな遺伝学的視点 https://news.medxy.ai/vi/cpeb3-alt-polyadenylation-2/Medxy AIvi2026-09-05T11:25:26-07:00Giải mã polyadenyl hóa thay thế do CPEB3 điều hòa: Một góc nhìn di truyền mới về tiên lượng ung thư biểu mô tế bào gan https://news.medxy.ai/decoding-cpeb3-regulated-alternative-polyadenylation-a-new-genetic-lens-on-hepatocellular-carcinoma-prognosis/Medxy AIen2026-09-05T11:25:06-07:00Decoding CPEB3-Regulated Alternative Polyadenylation: A New Genetic Lens on Hepatocellular Carcinoma Prognosis https://news.medxy.ai/zh/achalasia-esophageal-cancer/Medxy AIzh2026-09-05T11:24:24-07:00贲门失弛缓症与食管癌风险：对鳞癌和腺癌影响并不相同——来自北欧大规模病例对照研究的启示 https://news.medxy.ai/ja/achalasia-esophageal-cancer-risk/Medxy AIja2026-09-05T11:24:04-07:00アカラシアは食道扁平上皮癌と腺癌のリスクにどう影響するのか：北欧5か国の大規模症例対照研究から見えたこと https://news.medxy.ai/vi/achalasia-esophageal-cancer-risk-2/Medxy AIvi2026-09-05T11:23:43-07:00Achalasia làm tăng nguy cơ ung thư thực quản khác nhau: bằng chứng từ nghiên cứu bệnh-chứng quy mô lớn ở Bắc Âu https://news.medxy.ai/achalasia-and-its-differential-impact-on-esophageal-squamous-cell-carcinoma-and-adenocarcinoma-risk-insights-from-a-large-nordic-case-control-study/Medxy AIen2026-09-05T11:23:22-07:00Achalasia and Its Differential Impact on Esophageal Squamous Cell Carcinoma and Adenocarcinoma Risk: Insights from a Large Nordic Case-Control Study https://news.medxy.ai/zh/cle-diet-ibs-trial/Medxy AIzh2026-09-05T11:22:32-07:00CLE指导排除饮食未能改善肠易激综合征症状：随机对照试验 https://news.medxy.ai/ja/70704-2/Medxy AIja2026-09-05T11:22:16-07:00CLE（共焦点レーザー内視鏡）ガイド下除去食は過敏性腸症候群の症状を改善しない：無作為化比較試験 https://news.medxy.ai/vi/cle-diet-ibs/Medxy AIvi2026-09-05T11:21:58-07:00Chế độ ăn loại trừ theo CLE không giúp cải thiện triệu chứng IBS trong thử nghiệm có đối chứng https://news.medxy.ai/confocal-laser-endomicroscopy-guided-exclusion-diet-fails-to-improve-ibs-symptoms-in-controlled-trial/Medxy AIen2026-09-05T11:21:40-07:00Confocal Laser Endomicroscopy-Guided Exclusion Diet Fails to Improve IBS Symptoms in Controlled Trial https://news.medxy.ai/zh/70697-2/Medxy AIzh2026-09-05T11:21:01-07:00急性缺血性卒中患者 EQ-5D-5L 评分中与年龄相关的偏倚探究：基于 ACT 试验的启示 https://news.medxy.ai/ja/eq5d5l-age-bias/Medxy AIja2026-09-05T11:20:45-07:00急性虚血性脳卒中におけるEQ-5D-5Lの年齢関連バイアスを検証する：ACT試験から得られた知見 https://news.medxy.ai/vi/eq5d-5l-stroke-age-bias/Medxy AIvi2026-09-05T11:20:24-07:00EQ-5D-5L ở bệnh nhân đột quỵ thiếu máu cục bộ cấp tính: thiên lệch theo tuổi có đáng lo ngại? Phân tích từ thử nghiệm ACT https://news.medxy.ai/assessing-age-related-bias-in-eq-5d-5l-quality-of-life-measures-among-acute-ischemic-stroke-patients-insights-from-the-act-trial/Medxy AIen2026-09-05T11:20:06-07:00Assessing Age-Related Bias in EQ-5D-5L Quality of Life Measures Among Acute Ischemic Stroke Patients: Insights from the ACT Trial https://news.medxy.ai/zh/bckdk-hypoxia-target/Medxy AIzh2026-09-05T11:19:17-07:00BCKDK：揭示一种新型缺氧敏感靶点，为减轻脑缺血损伤提供新思路 https://news.medxy.ai/ja/70684-2/Medxy AIja2026-09-05T11:18:59-07:00BCKDK：新規の低酸素応答性標的の解明と、脳虚血性損傷の軽減に向けた新たな知見の提示 https://news.medxy.ai/vi/70681-2/Medxy AIvi2026-09-05T11:18:38-07:00BCKDK: Hé lộ một đích tác động mới nhạy cảm với tình trạng thiếu oxy và mang lại những hiểu biết mới nhằm giảm thiểu tổn thương do thiếu máu cục bộ não https://news.medxy.ai/bckdk-unlocking-a-new-hypoxia-sensitive-target-to-mitigate-cerebral-ischemic-injury/Medxy AIen2026-09-05T11:18:18-07:00BCKDK: Unlocking a New Hypoxia-Sensitive Target to Mitigate Cerebral Ischemic Injury https://news.medxy.ai/zh/70675-2/Medxy AIzh2026-09-05T11:17:32-07:00解析迟发性不明原因癫痫中阿尔茨海默病病理、睡眠障碍与认知功能下降之间的关联 https://news.medxy.ai/ja/70673-2/Medxy AIja2026-09-05T11:17:13-07:00発症時期が遅く原因不明のてんかんにおける、アルツハイマー病の病理、睡眠障害、および認知機能低下の関連の解明 https://news.medxy.ai/vi/70671-2/Medxy AIvi2026-09-05T11:16:50-07:00Làm sáng tỏ mối liên hệ giữa bệnh lý Alzheimer, rối loạn giấc ngủ và suy giảm nhận thức trong chứng động kinh khởi phát muộn không rõ nguyên nhân https://news.medxy.ai/alzheimers-epilepsy-link/Medxy AIen2026-09-05T11:16:31-07:00Unraveling the Link Between Alzheimer’s Pathology, Sleep Disturbances, and Cognitive Decline in Late-Onset Unexplained Epilepsy https://news.medxy.ai/zh/alzheimers-tay-sachs-progress/Medxy AIzh2026-09-05T11:15:48-07:00解码唐氏综合征中阿尔茨海默病进展：血液蛋白组动态的启示 https://news.medxy.ai/ja/alzheimers-progression-down-syndrome/Medxy AIja2026-09-05T11:15:29-07:00血中プロテオームの変動から読み解く、ダウン症候群におけるアルツハイマー病進行 https://news.medxy.ai/vi/alzheimer-down-syndrome/Medxy AIvi2026-09-05T11:15:08-07:00Làm sáng tỏ tiến triển bệnh Alzheimer ở hội chứng Down qua động học proteome máu https://news.medxy.ai/unraveling-alzheimers-disease-progression-in-down-syndrome-via-blood-proteome-dynamics/Medxy AIen2026-09-05T11:14:47-07:00Unraveling Alzheimer’s Disease Progression in Down Syndrome via Blood Proteome Dynamics https://news.medxy.ai/evaluating-tirofiban-plus-aspirin-in-branch-atheromatous-disease-stroke-insights-from-the-strategy-trial/Medxy AIen2026-09-05T11:14:00-07:00Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial https://news.medxy.ai/zh/guanabenz-safety-efficacy/Medxy AIzh2026-09-05T11:13:16-07:00Guanabenz用于早发型消失性白质病变的安全性与疗效：来自1/2期单臂试验的启示 https://news.medxy.ai/ja/guane-benz-vwm-safety/Medxy AIja2026-09-05T11:12:54-07:00早期発症VWMに対するグアナベンズの安全性と有効性：第1/2相単群試験からの知見 https://news.medxy.ai/vi/guanabenz-early-childhood-white-matter-disease/Medxy AIvi2026-09-05T11:12:32-07:00Guanabenz ở bệnh chất trắng mất dần khởi phát từ sớm ở trẻ nhỏ: độ an toàn và hiệu quả từ thử nghiệm đơn nhánh pha 1/2 https://news.medxy.ai/safety-and-efficacy-of-guanabenz-in-early-childhood-onset-vanishing-white-matter-insights-from-a-phase-1-2-single-arm-trial/Medxy AIen2026-09-05T11:12:10-07:00Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial https://news.medxy.ai/zh/antiepileptic-drugs-pregnancy/Medxy AIzh2026-09-05T11:11:18-07:00妊娠期抗癫痫发作药物使用：EURAP 登记研究揭示的胎儿生长影响 https://news.medxy.ai/ja/antiepileptic-drugs-pregnancy-2/Medxy AIja2026-09-05T11:11:01-07:00妊娠中の抗てんかん薬使用と胎児発育への影響：EURAP登録研究からの示唆 https://news.medxy.ai/vi/antiepileptics-pregnancy-impact/Medxy AIvi2026-09-05T11:10:41-07:00Thuốc chống co giật trong thai kỳ: Ảnh hưởng đến tăng trưởng thai nhi từ cơ sở đăng ký EURAP https://news.medxy.ai/antiseizure-medication-use-during-pregnancy-implications-for-fetal-growth-from-the-eurap-registry/Medxy AIen2026-09-05T11:10:22-07:00Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry https://news.medxy.ai/zh/mild-lt4-suppresses-tsh/Medxy AIzh2026-09-05T11:09:30-07:00左甲状腺素轻度抑制TSH可升高rT3而不影响fT3：主动监测甲状腺乳头状微癌患者的研究 https://news.medxy.ai/ja/levothyroxine-tsh-suppression/Medxy AIja2026-09-05T11:09:12-07:00レボチロキシンによる軽度TSH抑制は、経過観察中の甲状腺機能正常乳頭状甲状腺微小癌患者でfT3を変えずに逆T3を上昇させる https://news.medxy.ai/vi/levothyroxine-tsh-inhibition/Medxy AIvi2026-09-05T11:08:52-07:00Ức chế TSH nhẹ do Levothyroxine làm tăng reverse T3 mà không làm đổi fT3 ở bệnh nhân ung thư vi nhú tuyến giáp có chức năng tuyến giáp bình thường đang theo dõi tích cực https://news.medxy.ai/levothyroxine-induced-mild-tsh-suppression-elevates-reverse-t3-without-altering-ft3-in-euthyroid-papillary-thyroid-microcarcinoma-patients-on-active-surveillance/Medxy AIen2026-09-05T11:08:33-07:00Levothyroxine-Induced Mild TSH Suppression Elevates Reverse T3 without Altering fT3 in Euthyroid Papillary Thyroid Microcarcinoma Patients on Active Surveillance https://news.medxy.ai/zh/70630-2/Medxy AIzh2026-09-05T11:07:44-07:00解析1型糖尿病的遗传背景：HLA-DR3与DR4对疾病进展的不同影响 https://news.medxy.ai/ja/type-1-diabetes-genetics/Medxy AIja2026-09-05T11:07:26-07:001型糖尿病の遺伝的背景を解き明かす：HLA-DR3とDR4がもたらす疾患進行の異なる影響 https://news.medxy.ai/vi/70628-2/Medxy AIvi2026-09-05T11:07:06-07:00Giải mã nền tảng di truyền của bệnh đái tháo đường tuýp 1: Tác động khác biệt của HLA-DR3 và DR4 đối với sự tiến triển của bệnh https://news.medxy.ai/unraveling-genetic-pathways-in-type-1-diabetes-distinct-hla-dr3-and-dr4-effects-on-disease-progression/Medxy AIen2026-09-05T11:06:46-07:00Unraveling Genetic Pathways in Type 1 Diabetes: Distinct HLA-DR3 and DR4 Effects on Disease Progression https://news.medxy.ai/zh/decoding-type-2-diabetes/Medxy AIzh2026-09-04T18:05:51-07:00解码不同2型糖尿病亚型中的胰岛单细胞转录组异质性 https://news.medxy.ai/ja/type-2-diabetes-subtypes/Medxy AIja2026-09-04T18:05:33-07:002型糖尿病サブタイプにおける膵島単一細胞トランスクリプトーム多様性の解読 https://news.medxy.ai/vi/70619-2/Medxy AIvi2026-09-04T18:05:11-07:00Giải mã sự không đồng nhất về phiên mã đơn bào của các tiểu đảo tụy trên các phân nhóm bệnh đái tháo đường tuýp 2 https://news.medxy.ai/decoding-pancreatic-islet-single-cell-transcriptomic-diversity-across-type-2-diabetes-subtypes/Medxy AIen2026-09-04T18:04:51-07:00Decoding Pancreatic Islet Single-Cell Transcriptomic Diversity Across Type 2 Diabetes Subtypes https://news.medxy.ai/zh/eti-cf-glucose-impact/Medxy AIzh2026-09-04T18:03:57-07:00ETI治疗对囊性纤维化青少年葡萄糖代谢的影响：来自连续血糖监测的启示 https://news.medxy.ai/ja/cf-impact-glucose/Medxy AIja2026-09-04T18:03:39-07:00嚢胞性線維症の若年患者におけるエレキサカフトール／テザカフトール／イバカフトール療法が糖代謝に及ぼす影響：持続血糖モニタリングから得られた知見 https://news.medxy.ai/vi/eti-glucose-metabolism/Medxy AIvi2026-09-04T18:03:18-07:00ETI cải thiện chuyển hóa glucose ở trẻ và thanh thiếu niên mắc xơ nang: góc nhìn từ theo dõi đường huyết liên tục https://news.medxy.ai/impact-of-elexacaftor-tezacaftor-ivacaftor-therapy-on-glucose-metabolism-in-youths-with-cystic-fibrosis-insights-from-continuous-glucose-monitoring/Medxy AIen2026-09-04T18:02:59-07:00Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Glucose Metabolism in Youths with Cystic Fibrosis: Insights from Continuous Glucose Monitoring https://news.medxy.ai/approach-to-the-patient-theranostics-as-precision-medicine-for-neuroendocrine-tumors/Medxy AIen2026-09-04T18:02:07-07:00Approach to the Patient: Theranostics as Precision Medicine for Neuroendocrine Tumors https://news.medxy.ai/zh/charcot-neuroarthropathy-risk/Medxy AIzh2026-09-04T18:01:23-07:00糖尿病中的Charcot神经骨关节病：区域队列研究揭示住院、截肢与死亡风险显著升高 https://news.medxy.ai/ja/charcot-neuroarthropathy-risk-2/Medxy AIja2026-09-04T18:01:05-07:00糖尿病に合併するCharcot神経骨関節症：地域コホート研究で明らかになった入院・切断・死亡リスクの高さ https://news.medxy.ai/charcot-neuro-osteoarthropathy-in-diabetes-high-risk-of-hospitalization-amputation-and-mortality-revealed-by-regional-cohort-study/Medxy AIen2026-09-04T18:00:26-07:00Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort Study https://news.medxy.ai/zh/gestational-diabetes-insights/Medxy AIzh2026-09-04T17:59:38-07:00妊娠期糖尿病：25年研究揭示早期风险、预防与远期结局的新认识 https://news.medxy.ai/ja/gestational-diabetes-insights-2/Medxy AIja2026-09-04T17:59:21-07:00妊娠糖尿病の新たな理解：早期リスク、予防、長期転帰を25年の研究から読み解く https://news.medxy.ai/vi/gestational-diabetes/Medxy AIvi2026-09-04T17:58:59-07:00Đái tháo đường thai kỳ: Những phát hiện sau 25 năm nghiên cứu về nguy cơ sớm, phòng ngừa và hậu quả lâu dài https://news.medxy.ai/gestational-diabetes-mellitus-insights-from-25-years-of-research-on-early-risk-prevention-and-long-term-outcomes/Medxy AIen2026-09-04T17:58:39-07:00Gestational Diabetes Mellitus: Insights from 25 Years of Research on Early Risk, Prevention, and Long-Term Outcomes https://news.medxy.ai/zh/sglt2-dka-risk/Medxy AIzh2026-09-04T17:57:55-07:002型糖尿病使用SGLT2抑制剂的酮症酸中毒风险：来自斯堪的纳维亚队列研究的启示 https://news.medxy.ai/ja/70570-2/Medxy AIja2026-09-04T17:57:37-07:002型糖尿病におけるSGLT2阻害薬使用に伴うケトアシドーシスのリスク：北欧のコホート研究からの知見 https://news.medxy.ai/vi/70569-2/Medxy AIvi2026-09-04T17:57:15-07:00Nguy cơ nhiễm toan ceton liên quan đến việc sử dụng thuốc ức chế SGLT2 ở bệnh nhân đái tháo đường tuýp 2: Những hiểu biết từ các nghiên cứu đoàn hệ tại Scandinavia https://news.medxy.ai/ketoacidosis-risk-with-sglt2-inhibitors-in-type-2-diabetes-insights-from-a-scandinavian-cohort-study/Medxy AIen2026-09-04T17:56:55-07:00Ketoacidosis Risk with SGLT2 Inhibitors in Type 2 Diabetes: Insights from a Scandinavian Cohort Study https://news.medxy.ai/zh/heart-failure-management-2/Medxy AIzh2026-09-04T17:56:06-07:00优化心衰管理：医院参与GWTG-HF项目对药物治疗与患者结局的影响 https://news.medxy.ai/ja/heart-failure-treatment/Medxy AIja2026-09-04T17:55:48-07:00心不全診療を前進させる―GWTG-HF参加が薬物療法と転帰に及ぼす影響 https://news.medxy.ai/vi/improving-heart-failure-care/Medxy AIvi2026-09-04T17:55:29-07:00Nâng cao chăm sóc suy tim: Tác động của việc bệnh viện tham gia Get With The Guidelines-Heart Failure lên điều trị y khoa và kết cục người bệnh https://news.medxy.ai/enhancing-heart-failure-care-impact-of-get-with-the-guidelines-heart-failure-hospital-participation-on-medical-therapy-and-patient-outcomes/Medxy AIen2026-09-04T17:55:07-07:00Enhancing Heart Failure Care: Impact of Get With The Guidelines-Heart Failure Hospital Participation on Medical Therapy and Patient Outcomes https://news.medxy.ai/zh/childhood-bp-heart-rate-genetics/Medxy AIzh2026-09-04T17:54:14-07:00儿童期血压与心率的遗传学新发现：对成人心代谢健康的启示 https://news.medxy.ai/ja/pediatric-blood-pressure-genetics/Medxy AIja2026-09-04T17:53:52-07:00小児期の血圧・心拍数に関わる遺伝的知見：成人期の心代謝性健康への示唆 https://news.medxy.ai/vi/genetics-blood-pressure-heart-rate/Medxy AIvi2026-09-04T17:53:29-07:00Khám phá di truyền về huyết áp và nhịp tim ở trẻ em: gợi mở cho sức khỏe tim mạch-chuyển hóa ở người lớn https://news.medxy.ai/genetic-insights-into-childhood-blood-pressure-and-heart-rate-implications-for-adult-cardiometabolic-health/Medxy AIen2026-09-04T17:53:09-07:00Genetic Insights into Childhood Blood Pressure and Heart Rate: Implications for Adult Cardiometabolic Health https://news.medxy.ai/zh/vroni-family-hypercholesterolemia/Medxy AIzh2026-09-04T17:52:20-07:00VRONI 研究：推进儿童家族性高胆固醇血症遗传筛查，助力早期心血管健康提升 https://news.medxy.ai/ja/vroni-child-fh-screening/Medxy AIja2026-09-04T17:52:02-07:00VRONI研究：小児FH遺伝学的スクリーニングを前進させ、早期の心血管保護につなげる https://news.medxy.ai/vi/vroni-genetic-screening/Medxy AIvi2026-09-04T17:51:42-07:00Nghiên cứu VRONI: Đột phá sàng lọc di truyền ở trẻ em đối với tăng cholesterol máu gia đình, hướng tới sức khỏe tim mạch sớm tốt hơn https://news.medxy.ai/vroni-study-advancing-pediatric-genetic-screening-for-familial-hypercholesterolaemia-to-improve-early-cardiovascular-health/Medxy AIen2026-09-04T17:51:23-07:00VRONI Study: Advancing Pediatric Genetic Screening for Familial Hypercholesterolaemia to Improve Early Cardiovascular Health https://news.medxy.ai/zh/early-lipid-lowering/Medxy AIzh2026-09-04T17:50:26-07:00方案化早期强化降脂可显著提升急性冠脉综合征后LDL-C达标率：BRIDGE试验新见解 https://news.medxy.ai/ja/ldl-c-management-improvement/Medxy AIja2026-09-04T17:50:09-07:00ACS後のLDL-C管理を大幅に改善：BRIDGE試験が示したプロトコール主導の早期集中的脂質治療の効果 https://news.medxy.ai/vi/early-lipid-management/Medxy AIvi2026-09-04T17:49:50-07:00Quản lý lipid sớm theo quy trình giúp tăng mạnh tỷ lệ đạt mục tiêu LDL-C sau hội chứng vành cấp: Kết quả từ thử nghiệm BRIDGE https://news.medxy.ai/zh/cold-wave-heatwave-heart-failure/Medxy AIzh2026-09-04T17:48:47-07:00寒潮、热浪与环境温度波动如何影响心力衰竭住院风险：来自瑞典及其他地区的证据 https://news.medxy.ai/ja/70545-2/Medxy AIja2026-09-04T17:48:30-07:00寒波、熱波、および気温の変動が心不全による入院リスクに及ぼす影響：スウェーデンおよびその他の地域からのエビデンス https://news.medxy.ai/vi/heat-temperature-heart-failure/Medxy AIvi2026-09-04T17:48:07-07:00Rét, nắng nóng và biến động nhiệt độ môi trường ảnh hưởng ra sao đến nguy cơ nhập viện vì suy tim: bằng chứng từ Thụy Điển và các nghiên cứu liên quan https://news.medxy.ai/impact-of-cold-spells-heat-waves-and-ambient-temperature-variations-on-heart-failure-hospitalization-risk-insights-from-sweden-and-beyond/Medxy AIen2026-09-04T17:47:45-07:00Impact of Cold Spells, Heat Waves, and Ambient Temperature Variations on Heart Failure Hospitalization Risk: Insights from Sweden and Beyond https://news.medxy.ai/zh/pus7-pulmonary-hypertension/Medxy AIzh2026-09-04T17:46:49-07:00揭开PUS7在肺动脉高压中的作用：驱动血管重塑的新型表观遗传因素 https://news.medxy.ai/ja/pus7-pulmonary-hypertension-3/Medxy AIja2026-09-04T17:46:32-07:00肺高血圧症における PUS7 の役割を解明：血管リモデリングを駆動する新規エピジェネティック因子 https://news.medxy.ai/vi/pus7-pulmonary-hypertension-2/Medxy AIvi2026-09-04T17:46:10-07:00PUS7 và vai trò mới trong tăng áp động mạch phổi: động lực biểu sinh thúc đẩy tái cấu trúc mạch máu https://news.medxy.ai/unveiling-pus7s-role-in-pulmonary-hypertension-a-novel-epigenetic-driver-of-vascular-remodeling/Medxy AIen2026-09-04T17:45:51-07:00Unveiling PUS7’s Role in Pulmonary Hypertension: A Novel Epigenetic Driver of Vascular Remodeling https://news.medxy.ai/zh/gp1-pet-ct-thrombosis/Medxy AIzh2026-09-04T17:44:58-07:00[18F]GP1 PET/CT 直视血栓：缺血性卒中诊断迎来新突破 https://news.medxy.ai/ja/70535-2/Medxy AIja2026-09-04T17:44:41-07:00[18F]GP1 PET/CTによる血栓の可視化：虚血性脳卒中診断における新たなブレイクスルー https://news.medxy.ai/vi/stroke-new-perspective/Medxy AIvi2026-09-04T17:44:18-07:00Đột quỵ dưới góc nhìn mới: Chẩn đoán huyết khối không xâm lấn bằng [18F]GP1 PET/CT https://news.medxy.ai/revolutionizing-stroke-diagnosis-noninvasive-thrombus-imaging-with-18fgp1-pet-ct/Medxy AIen2026-09-04T17:43:57-07:00Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT https://news.medxy.ai/zh/hpv-anal-abnormalities/Medxy AIzh2026-09-04T15:41:42-07:00实体器官移植受者 HPV 相关肛门发育异常：移植特异性黏膜免疫失调新解 https://news.medxy.ai/ja/hpv-anal-dysplasia/Medxy AIja2026-09-04T15:41:13-07:00固形臓器移植後のHPV関連肛門異形成――移植特異的な粘膜免疫障害の解明 https://news.medxy.ai/vi/hpv-anal-dysplasia-transplant-3/Medxy AIvi2026-09-04T15:40:43-07:00Loạn sản hậu môn liên quan HPV ở người ghép tạng đặc: làm rõ rối loạn miễn dịch niêm mạc đặc hiệu sau ghép https://news.medxy.ai/hpv-associated-anal-dysplasia-in-solid-organ-transplant-recipients-unraveling-transplant-specific-mucosal-immune-dysfunction/Medxy AIen2026-09-04T15:40:12-07:00HPV-Associated Anal Dysplasia in Solid Organ Transplant Recipients: Unraveling Transplant-Specific Mucosal Immune Dysfunction https://news.medxy.ai/zh/ecmo-rehabilitation-guide/Medxy AIzh2026-09-04T15:39:18-07:00ECMO 支持期间如何推进康复：一项回顾性队列研究的启示 https://news.medxy.ai/ja/ecmo-rehabilitation-2/Medxy AIja2026-09-04T15:38:52-07:00ECMO補助下のリハビリテーションをどう進めるか：後ろ向きコホート研究から見えた知見 https://news.medxy.ai/vi/ecmo-rehabilitation/Medxy AIvi2026-09-04T15:38:25-07:00Phục hồi chức năng trong thời gian hỗ trợ ECMO: Những phát hiện từ một nghiên cứu đoàn hệ hồi cứu